BMS-844421
- Generic Name
- BMS-844421
Safety Study of BMS-844421 for Treatment of Hypercholesterolemia
Phase 1
Terminated
- Conditions
- HypercholesterolemiaAtherosclerosis
- Interventions
- Drug: 0.9% sodium chloride injection solution
- First Posted Date
- 2010-03-08
- Last Posted Date
- 2011-01-26
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 40
- Registration Number
- NCT01082562
- Locations
- 🇩🇪
Local Institution, Berlin, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath